astrazeneca news - Search News

AstraZeneca, China

AstraZeneca talks up US growth as China problems fester

AstraZeneca Plc is increasingly looking to the US for growth as its once fast-expanding China business faces challenges amid a probe that has battered the drugmaker’s share price.

The Financial Times · 3d

AstraZeneca chief says group takes China probe ‘very seriously’

AstraZeneca chief executive Pascal Soriot said the company took the detention of its China president “very seriously”, as the drugmaker raised its guidance for a second straight quarter on the back of strong sales of cancer medicines.

Reuters on MSN · 3d

AstraZeneca CEO says detained China chief has a lawyer but 'we have no information'

AstraZeneca's CEO said on Tuesday that the company's China president Leon Wang, who last month was detained by Chinese authorities, has a lawyer he is in touch with, but "we have no information as a company".

Barron's · 3d

Pharma Giant AstraZeneca Takes China Probes 'Very Seriously'

British pharmaceutical giant AstraZeneca on Tuesday said it takes "very seriously" China's investigations into potential illegal data collection and drug imports by the group that caused the detention of its China boss.

2don MSN

Healthy Returns: AstraZeneca expands U.S. investment plan on confidence in economy

A version of this article first appeared in CNBC's Healthy Returns newsletter, which brings the latest health-care news ...

AstraZeneca lifts 2024 outlook after Q3 beat, doubles down on US investments

Drugmaker AstraZeneca lifted its annual sales and profit forecast for the second time this year on Tuesday, helped by strong ...

STAT3d

Pharmalittle: We’re reading about 23andMe retrenching, AstraZeneca reworking cancer drug plans, and more

In closing its therapeutics division and laying off 200 people, 23andMe ended an audacious bet it made nearly a decade ago — ...

Outsourcing-pharma1d

AstraZeneca doubles down on US manufacturing with $3.5 billion investment

AstraZeneca has become the latest big pharma company to devote new cash to its US manufacturing muscle this year as it ...

AstraZeneca says detained China head has lawyer, but company still in dark

AstraZeneca's China president Leon Wang, who was detained last month by Chinese authorities, is in touch with a lawyer but ...

Hosted on MSN3d

AstraZeneca Expands U.S. Investment Plan

AstraZeneca said it plans to pump $2 billion in new investment into the U.S., one of the first major foreign companies to ...

Bisnow2d

AstraZeneca To Invest $3.5B To Grow U.S. Footprint

Cambridge, England-based biopharmaceutical giant AstraZeneca is pouring billions of dollars into properties in the United ...

STAT3d

AstraZeneca, Daiichi Sankyo change strategy on closely watched cancer drug

LONDON — AstraZeneca said Tuesday it has had to resubmit a closely watched medicine for U.S. approval in a different form of ...

Business Insider2d

AstraZeneca: Overcoming Short-term Challenges with Robust Long-term Potential

Bernstein analyst Justin Smith maintained a Buy rating on AstraZeneca (AZN – Research Report) today and set a price target of p18,000.00. Justin Smith has given his Buy rating due to a combination ...

AstraZeneca Raises Outlook on Earnings, Sales Beat

The pharmaceutical giant raised its full-year guidance after third-quarter revenue and core earnings per share topped ...

Reuters3d

AstraZeneca: 450 million pound investment in UK under review amid talks with govt

LONDON, Nov 12 (Reuters) - London-listed drugmaker AstraZeneca (AZN.L), opens new tab said its plan to invest 450 million ...

Business Insider2d

AstraZeneca: Strong Q3 Growth and Strategic Moves Justify Buy Rating

Eric Le Berrigaud, an analyst from Stifel Nicolaus, reiterated the Buy rating on AstraZeneca (AZN – Research Report). The associated price target remains the same with p14,100.00. Eric Le Berrigaud ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results

AstraZeneca, China

Related topics